BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 3266208)

  • 1. Analysis of DR and DQ gene products of the DR4 haplotype in patients with IDDM: possible involvement of more than one locus.
    Monos DS; Mickelson E; Hansen JA; Baker L; Zmijewski CM; Kamoun M
    Hum Immunol; 1988 Dec; 23(4):289-99. PubMed ID: 3266208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A diabetes-susceptible HLA haplotype is best defined by a combination of HLA-DR and -DQ alleles.
    Sheehy MJ; Scharf SJ; Rowe JR; Neme de Gimenez MH; Meske LM; Erlich HA; Nepom BS
    J Clin Invest; 1989 Mar; 83(3):830-5. PubMed ID: 2784133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T-cell-defined DR4 subtypes as markers for type 1 diabetes.
    Rowe JR; Mickelson EM; Hansen JA; MacDonald MJ; Allen CI; Gabbay KH; Yunis EJ; Sheehy MJ
    Hum Immunol; 1988 May; 22(1):51-60. PubMed ID: 3260586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sequence analysis of HLA class II genes from insulin-dependent diabetic individuals.
    Horn GT; Bugawan TL; Long CM; Manos MM; Erlich HA
    Hum Immunol; 1988 Apr; 21(4):249-63. PubMed ID: 3372263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The molecular basis for HLA class II associations with rheumatoid arthritis.
    Nepom GT; Hansen JA; Nepom BS
    J Clin Immunol; 1987 Jan; 7(1):1-7. PubMed ID: 3558732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional analysis of MHC class II-restricted T cells derived from a Caucasian with a DR4, Dw15, DQw8 haplotype.
    Celis E; Karr RW; Gregersen PK; Reinsmoen NL
    Hum Immunol; 1990 Sep; 29(1):31-41. PubMed ID: 2211188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HLA-Dw clusters associated with DR4 in Israeli Jews and the definition of a new DR4 associated Dw subtype: Dw"SHA".
    Cohen N; Mickelson E; Amar A; Battat S; Hansen JA; Brautbar C
    Hum Immunol; 1987 Jul; 19(3):179-88. PubMed ID: 3497909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Restriction fragment length polymorphism analysis of HLA haplotypes in families with type I diabetes mellitus.
    Badenhoop K; Schwarz G; Bingley P; Lewis V; Drummond V; Gale EA; Bottazzo GF
    Tissue Antigens; 1990 Jan; 35(1):32-9. PubMed ID: 1968292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA-DQ beta 3.1 allele is a determinant of susceptibility to DR4-associated rheumatoid arthritis.
    Lanchbury JS; Sakkas LI; Marsh SG; Bodmer JG; Welsh KI; Panayi GS
    Hum Immunol; 1989 Sep; 26(1):59-71. PubMed ID: 2789210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Particular HLA-DQ alpha beta heterodimer associated with IDDM susceptibility in both DR4-DQw4 Japanese and DR4-DQw8/DRw8-DQw4 whites.
    Rønningen KS; Gjertsen HA; Iwe T; Spurkland A; Hansen T; Thorsby E
    Diabetes; 1991 Jun; 40(6):759-63. PubMed ID: 2040392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA class II typing using oligonucleotide probes.
    Robinson DM; Holbeck S; Seyfried C; Byers P; Palmer J; Nepom GT
    Genet Epidemiol; 1989; 6(1):27-30. PubMed ID: 2499503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HLA-DQw3.2 allele of the DR4 haplotype is associated with insulin-dependent diabetes; correlation between DQ beta restriction fragments and DQ beta chain variation.
    Monos DS; Spielman RS; Gogolin KJ; Radka SF; Baker L; Zmijewski CM; Kamoun M
    Immunogenetics; 1987; 26(4-5):299-303. PubMed ID: 2888728
    [No Abstract]   [Full Text] [Related]  

  • 13. Dissection of HLA class II haplotypes in HLA-DR4 homozygous individuals.
    Tilanus MG; Morolli B; van Eggermond MC; Schreuder GM; de Vries RR; Giphart MJ
    Immunogenetics; 1986; 23(5):333-40. PubMed ID: 3011659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A deletion mutant defines DQ beta variants with DR4 positive DQw3 positive haplotypes.
    Nepom BS; Kim SJ; Nepom GT
    Hum Immunol; 1986 Oct; 17(2):87-93. PubMed ID: 2875977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diversity in HLA-DR4-related DR,DQ haplotypes in Australia, Oceania, and China.
    Gao X; Serjeantson SW
    Hum Immunol; 1991 Dec; 32(4):269-76. PubMed ID: 1783573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HLA DQ beta 3.2 identifies subtypes of DR4+ haplotypes permissive for IDDM.
    Robinson DM; Holbeck S; Palmer J; Nepom GT
    Genet Epidemiol; 1989; 6(1):149-54. PubMed ID: 2567255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HLA-DR4 associated Dw types in rheumatoid arthritis.
    Ollier W; Carthy D; Cutbush S; Okoye R; Awad J; Fielder A; Silman A; Festenstein H
    Tissue Antigens; 1989 Jan; 33(1):30-7. PubMed ID: 2565608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary association of HLA-DQw8 with type I diabetes in DR4 patients.
    Owerbach D; Gunn S; Gabbay KH
    Diabetes; 1989 Jul; 38(7):942-5. PubMed ID: 2786821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcomplementation of HLA genes in IDDM. HLA-DQ alpha- and beta-chains produce hybrid molecules in DR3/4 heterozygotes.
    Nepom BS; Schwarz D; Palmer JP; Nepom GT
    Diabetes; 1987 Jan; 36(1):114-7. PubMed ID: 3491769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DQ beta sequences in HLA-DR4 haplotypes.
    Hilden JM; Curtsinger JM; Cairns JS; Bach FH
    Hum Immunol; 1987 Apr; 18(4):261-4. PubMed ID: 3494717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.